SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 115 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,032,044 | -73.0% | 266,678 | -58.4% | 0.00% | – |
| Q2 2023 | $3,825,074 | +192.4% | 641,791 | +60.4% | 0.00% | – |
| Q1 2023 | $1,308,295 | +485.6% | 400,090 | +607.4% | 0.00% | – |
| Q4 2022 | $223,392 | -79.5% | 56,555 | -68.8% | 0.00% | – |
| Q3 2022 | $1,088,000 | +107.2% | 181,400 | +122.0% | 0.00% | – |
| Q2 2022 | $525,000 | -60.6% | 81,700 | -49.4% | 0.00% | – |
| Q1 2022 | $1,333,000 | -58.4% | 161,460 | -22.1% | 0.00% | – |
| Q4 2021 | $3,208,000 | +173.7% | 207,134 | +298.1% | 0.00% | – |
| Q3 2021 | $1,172,000 | +25.5% | 52,028 | +9.5% | 0.00% | – |
| Q2 2021 | $934,000 | – | 47,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |